AKT1 and breast carcinoma: Additionally, WWP1 was found to suppress PTEN antagonism of PI3K/AKT signaling in prostate and breast cancer, and a natural potent WWP1 inhibitor I3C effectively inhibits tumorigenesis driven by the PI3K-AKT pathway30,31.